scholarly journals Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions

2009 ◽  
Vol 18 (11) ◽  
pp. 2219-2230 ◽  
Author(s):  
Supachai Sakkhachornphop ◽  
Supat Jiranusornkul ◽  
Kanchanok Kodchakorn ◽  
Sawitree Nangola ◽  
Thira Sirisanthana ◽  
...  
2004 ◽  
Vol 78 (3) ◽  
pp. 1301-1313 ◽  
Author(s):  
Wenjie Tan ◽  
Kai Zhu ◽  
David J. Segal ◽  
Carlos F. Barbas ◽  
Samson A. Chow

ABSTRACT In order to establish a productive infection, a retrovirus must integrate the cDNA of its RNA genome into the host cell chromosome. While this critical process makes retroviruses an attractive vector for gene delivery, the nonspecific nature of integration presents inherent hazards and variations in gene expression. One approach to alleviating the problem involves fusing retroviral integrase to a sequence-specific DNA-binding protein that targets a defined chromosomal site. We prepared proteins consisting of wild-type or truncated human immunodeficiency virus type 1 (HIV-1) integrase fused to the synthetic polydactyl zinc finger protein E2C. The purified fusion proteins bound specifically to the 18-bp E2C recognition sequence as analyzed by DNase I footprinting. The fusion proteins were catalytically active and biased integration of retroviral DNA near the E2C-binding site in vitro. The distribution was asymmetric, and the major integration hot spots were localized within a 20-bp region upstream of the C-rich strand of the E2C recognition sequence. Integration bias was not observed with target plasmids bearing a mutated E2C-binding site or when HIV-1 integrase and E2C were added to the reaction as separate proteins. The results demonstrate that the integrase-E2C fusion proteins offer an efficient approach and a versatile framework for directing the integration of retroviral DNA into a predetermined DNA site.


2021 ◽  
Vol 20 ◽  
pp. 18-29
Author(s):  
Tristan A. Scott ◽  
Denis O’Meally ◽  
Nicole Anne Grepo ◽  
Citradewi Soemardy ◽  
Daniel C. Lazar ◽  
...  

2008 ◽  
Vol 4 (1) ◽  
pp. 103-115 ◽  
Author(s):  
James L. Buescher ◽  
Lindsey B. Martinez ◽  
Shinji Sato ◽  
Satoshi Okuyama ◽  
Tsuneya Ikezu

PLoS ONE ◽  
2014 ◽  
Vol 9 (8) ◽  
pp. e104908 ◽  
Author(s):  
Ronald Benjamin ◽  
Atoshi Banerjee ◽  
Kannan Balakrishnan ◽  
Ramya Sivangala ◽  
Sumanlatha Gaddam ◽  
...  

1995 ◽  
Vol 8 (4) ◽  
pp. 586-590 ◽  
Author(s):  
Xiaolan Yu ◽  
Yetrib Hathout ◽  
Catherine Fenselau ◽  
Raymond C. Sowder ◽  
Louis E. Henderson ◽  
...  

2018 ◽  
Vol 38 (5) ◽  
Author(s):  
Sutpirat Moonmuang ◽  
Somphot Saoin ◽  
Koollawat Chupradit ◽  
Supachai Sakkhachornphop ◽  
Nipan Israsena ◽  
...  

Lentiviral vectors have emerged as the most efficient system to stably transfer and insert genes into cells. By adding a tetracycline (Tet)-inducible promoter, transgene expression delivered by a lentiviral vector can be expressed whenever needed and halted when necessary. Here we have constructed a doxycycline (Dox)-inducible lentiviral vector which efficiently introduces a designed zinc finger protein, 2-long terminal repeat zinc-finger protein (2LTRZFP), into hematopoietic cell lines and evaluated its expression in pluripotent stem cells. As a result this lentiviral inducible system can regulate 2LTRZFP expression in the SupT1 T-cell line and in pluripotent stem cells. Using this vector, no basal expression was detected in the T-cell line and its induction was achieved with low Dox concentrations. Remarkably, the intracellular regulatory expression of 2LTRZFP significantly inhibited HIV-1 integration and replication in HIV-inoculated SupT1 cells. This approach could provide a potential tool for gene therapy applications, which efficiently control and reduce the side effect of therapeutic genes expression.


Sign in / Sign up

Export Citation Format

Share Document